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Abstract: Purpose: The research purpose is to effectively improve treatment effect of postoperative pancreatic cancer.
Approaches: Adjuvant radiotherapy and chemotherapy; Palliative radiotherapy is adpoted for patients whose pancreatic
cancer cannot be removed through excision. Comprehensive treatment approach is adopted where gemcitabine is added
during radiotherapy. Result: The treatment effect of palliative operation is a little bit better than the traditional operative
treatment, adoption of comprehensive treatment is obviously superior to the aforesaid two treatment approaches.
Conculsion: Comprehensive treatment effectively improves survival rate of patients, and the survival time is greatly
extended.
Operation is generally adopted for pancreatic cancer treatment, but the effect is unsatisfactory. The average
lifetime of patients after palliative operation treatment is only 5 to 76 months, and the survival rate after five years only
reaches 8% to 15%, while the curative effect of radical resection is a little bit better, but the survival rate after five years
also only reaches 12% to 24%, and the average lifetime is about 10 to 19 months. In recent years, with gradual progress
of medical treatment level, clinical cases of adopting radiotherapy for pancreatic cancer are increasing, but its main
effect is palliative or auxiliary. This article refers to plenty of documentation, makes thorough study of present situation
and progress of pancreatic cancer radiotherapy, put forward its own suggestions and opinions, and have certain
reference value.
Keywords: pancreatic cancer; radiotherapy; present situation; progress
Incidence of pancreatic cancer is comparatively low (about one ten-thousandth), but this disease has high fatality rate
and rapid development speed, and is an extremely dangerous malignant tumor (Survival rate of the patients after one
year is only 8%, and it is only 3% after five years). Operative treatment is traditional treatment method for pancreatic
cancer, but but the effect is unsatisfactory, while treatment effect of palliative operation is obviously improved (Survival
rate after five years can reach 8% to 15%). With improvement of medical treatment level, clinical cases of adopting
radiotherapy for pancreatic cancer are increasing, which provides basis for further research of pancreatic cancer
treatment.
1. Preoperative radio therapy of pancreatic cancer
1.1 The advantages of preoperative radiotherapy
Comparing with the postoperative chemotherapy, radiotherapy and chemotherapy, preoperative radiotherapy and
chemotherapy can significantly improve the resection rate, can reduce tumor spread, those spreads are caused by the
operation, which are sensitive to radiotherapy, and it can better oxygenate with tumor cells. According to the few
documentation and reports, the local recurrence rate is much lower than that of postoperative radiotherapy and
chemotherapy
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1.2 Palliative radiotherapy for pancreatic cancer that cannot be resected
Patients with pancreatic cancer also has such symptoms as gastrointestinal tract obstruction, losing weight, nausea and
vomit, inappetence, obstructive jaundice and ache, which bring overwhelming pain to them, meanwhile, it also leads to
significant reductions of life quality, severe impact and final death of patients. Therefore, radiotherapy should be
cautiously applied, especially for those patients with bad physical situation and extensive lesions. For those incurably ill
patients that local resection cannot by done, palliative radiotherapy should be used to relieve their symptoms.
Locally advanced pancreatic cancer that cannot be resected has bad prognosis. For comment on curative effect of
this kind of patients, survival situation, local control rate, life quality improvement rate and symptom relief rate of
patients should be comprehensively considered. In reports of Andre and others, during the process of clinical treatment
of locally advanced pancreatic cancer, radiotherapy, injection of 5-FU and cis-platinum are applied, regarding
to behavior status, 30% of them are deteriorated, 47% are stable, and 23% are improved; regarding to weight: 3.5% of
them gain weight, 7% are stable, 89.5% lose weight; Pain: 65% of them totally lose pain, 9% are relieved, 22% are
stable, and 4% are deteriorated. JIA Zhengeng and others in China reported that pain relief rate after radiotherapy of 45
cases of pancreatic cancer operation is 95.5% (43/45), including 55.5% (25/45) of total disappearing of pain. WU Zheng
and others reported that the total effective rate reached 76.1% after extracorporeal radiotherapy of 21 cases of pancreatic
cancer, hereinto: status of nine patients was obviously relieved, the pain of seven patients was totally relieved. We can
see from these materials that radiotherapy can effectively relieve the pain of patients for those with locally advanced
pancreatic cancer.
2.Postoperative radiotherapy of pancreatic cancer
Generally speaking, the approach that can effectively cure pancreatic cancer is still radical resection operation, but as
many major organs are around the pancreas, for example, spinal cord, kidney, liver, small intestine, duodenum and
stomach restrict eradication of the operation.
In order to further specify curative effect of auxiliary radiotherapy and chemotherapy after pancreatic cancer
radical surgical resection, RTOG of the U.S. started one random grouping research (RTOG-97-04) in August 1998 to
compare curative effect of application of 5-FU (group one) or gemcitabine (group two) before or after radiotherapy and
chemotherapy after pancreatic cancer radical surgical resection. The detailed scheme is: radiotherapy and
chemotherapy begin within three to six weeks after the operation. The first group uses 250 mg/m2 of 5-FU every day
for total three successive weeks; The second group uses 1000 mg/m2 of gemcitabine every day, once a week, total three
weeks. Radiotherapy and chemotherapy begin within one to two weeks after the aforesaid chemotherapy, meanwhile,
5-FU continues to be instilled. The radiotherapy scheme is 1.8Gy once every day, and the added dosage begins to be
changed till total dosage 50.1Gy / 5.5 weeks after 15Gy. Scheme of the first group is: the time rang of one period is rest
for two weeks and successive application for four weeks, total six weeks, 250 mg/(m2.d) of 5-FU keeps to be instilled
for total two periods. Scheme of second group is: the time rang of one period is rest for one week and successive
application for two weeks, total three weeks, 1000 mg/(m2.d) of gemcitabine is instilled once a week for total three
periods.
3. Radiotherapy and chemotherapy for postoperative pancreatic cancer
In recent years, gemcitabine is paid much attention during treatment of pancreatic cancer. Its main therapeutic scheme is
as follows:
Advanced Emergency Medicine Volume 6 Issue 2 | 2017 | 3
3.1 Radiotherapy adopts standard therapeutic scheme
1.8 Gy once a day, five times a week, and the total dosage is 50.4Gy; the dosage of gemcitabine is lower than the
standard dosage. According to the reports including that of Poggi, during one period of clinical research of
comprehensive treatment of gemcitabine and radiotherapy for pancreatic cancer which cannot be resected, the aforesaid
scheme is adopted for radiotherapy. Gemcitabine is used once a week for total five times. The dosage starts from 350
mg/m2, and is gradually increased, the final maximum tolerance dose is 440 mg/m2. During two periods of clinical
research of GALGB, therapeutic scheme of gemcitabine is twice a week (Medication is on Monday and Thursday), and
the appropriate dosage is 40 mg/m2.
3.2 Standard dosage of gemcitabine is applied
1.8 Gy once a day for total ten times of two successive weeks. After one week of rest, the aforesaid chemotherapy and
radiotherapy scheme are repeated. The total radiotherapy dosage is 50.4Gy, which is the same with the common
standard dosage, but is completed by three phases.
4.Other therapeutic techniques of pancreatic cancer
4.1 3D-CRT or IMRT
Domestic and foreign scholars are making clinical research of 3D-CRT or IMRT of pancreatic cancer. Currently, there is
no mature curative scheme. Seen from the existing limited materials, 3D-CRT or IMRT of pancreatic cancer has the
following features comparing with the conventional radiotherapy: (1) The target range is narrowed; (2) Many scholars
adopts unconventional partitioning method for irradiation. The total course of treatment is shortened with fewer
irradiation times and larger dosage of every time. Seen from limited clinical reports, short-term curative effect of this
technique is comparatively good, which can obviously reduce radiotherapy reaction and improve tolerance of the
patients. Scholars including Xu Weidong reported that they used three-dimensional stereotactic radiotherapy for 15
cases of pancreatic cancer that cannot be treated by surgery, and one-year survival rate reached 73.3%, two-year
survival rate reached 33.3%. Scholars including Yu Jinming reported that they used stereotactic radiotherapy for 13
cases of pancreatic cancer that cannot be treated by surgery, and one-year survival rate and two-year survival rate were
respectively 92.3% and 70%.
3D-CRT or IMRT of pancreatic cancer is still in the preliminary phase, demarcation of target volume, best
partitioning method, total dosage and other issues still need to be further specified in the clinical research in the future
and are worth further research.
4.2 Combination of tomotherapy and radiotherapy
Comparing with traditional curative method, the biggest feature of Tomotheraopy of pancreatic cancer is higher
conformation number of tumor dose and more precise of intensity adjustment of tumor dose, and finer dose adjustment
of normal tissues around the tumor, especially for such tumors with “complex position” as pancreatic cancer,
advantages of Tomotherapy are more obvious, and Tomotherapy can distinctly reduce occurrence rate of adverse
reaction of the tumor
4.3 Combination of particle implantation and radiotherapy
Pancreatic cancer is hypoxic tumor, has strong resistance to radioactive rays, and extremely sensistive to Gamma ray. A
small quantity of Gamma ray can destroy DNA. Radioactive particle I125 keeps emitting Gamma ray to prevent breeding
of tumor cells and has small damage to the surrounding normal tissues. I125 particle implantation to cure pancreatic
cancer cannot only significantly improve life quality of the patients and increase local control rate of the tumor, but also
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is expected to improve long-term survival rate, and it is a prospective treatment method for pancreatic cancer treatment.
I125 particle implantation is implementation among pamernant radioactive source tissues, CT, MRI or ultrasound
can work as imaging tool to guide particle implementation. Particle implementation under guidance of imaging can
completely meet outline of the tumor, get accurate conformation number, and the rays completely cover the target
section. The target section of the tumor can get the dose for radical curement of the tumor, and injectivity of the
surrounding normal tissues is very low, which will not cause severve acute or later period damage.
5.Conclusion
This article makes research on application of radiotherapy technique in treatment of pancreatic cancer based on
traditional treatment method of pancreatic cancer. Local control rate can be effectively increased through introduction of
new radiotherapy technique, and the effect on extension of life time of hte patients is obvious. As radiotherapy has
strong toxicity, the new adjuvant treatment method can reduce excision rate, and improve survival rate. With
introduction of mor new techniques, radiotherapy will have better effect on treatment of pancreatic cancer.
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